Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,734 papers from all fields of science
Search
Sign In
Create Free Account
Glucose Metabolism Disorders
Known as:
Disorders, Glucose Metabolism
, Metabolism Disorder, Glucose
, Disorder of Glucose Metabolism
Expand
Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Endocrine system
In Blood
Microbiological
chemically induced
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
M. Fischereder
,
U. Schönermarck
New England Journal of Medicine
2016
Corpus ID: 2927684
To the Editor: The EMPA-REG OUTCOME trial (Nov. 26 issue)1 showed relative-risk reductions of 38% in death from cardiovascular…
Expand
Review
2005
Review
2005
Cellulose: fascinating biopolymer and sustainable raw material.
D. Klemm
,
B. Heublein
,
H. Fink
,
A. Bohn
Angewandte Chemie
2005
Corpus ID: 33418512
As the most important skeletal component in plants, the polysaccharide cellulose is an almost inexhaustible polymeric raw…
Expand
Highly Cited
2005
Highly Cited
2005
The pathobiology of diabetic complications: a unifying mechanism.
M. Brownlee
Diabetes
2005
Corpus ID: 32296943
It’s a great honor to join the exceptional club of Banting Award winners, many of whom were my role models and mentors. In…
Expand
Review
2004
Review
2004
Use and abuse of HOMA modeling.
T. M. Wallace
,
J. Levy
,
D. Matthews
Diabetes Care
2004
Corpus ID: 2486896
Homeostatic model assessment (HOMA) is a method for assessing beta-cell function and insulin resistance (IR) from basal (fasting…
Expand
Review
2003
Review
2003
Follow-up report on the diagnosis of diabetes mellitus.
S. Genuth
,
K. Alberti
,
+16 authors
P. Zimmet
Diabetes Care
2003
Corpus ID: 11418123
In 1997, an International Expert Committee was convened to reexamine the classification and diagnostic criteria of diabetes…
Expand
Highly Cited
2001
Highly Cited
2001
Cardiovascular morbidity and mortality associated with the metabolic syndrome.
B. Isomaa
,
P. Almgren
,
+5 authors
L. Groop
Diabetes Care
2001
Corpus ID: 9090943
OBJECTIVE To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new…
Expand
Highly Cited
1998
Highly Cited
1998
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
M. Ricote
,
Andrew C. Li
,
T. Willson
,
C. Kelly
,
C. Glass
Nature
1998
Corpus ID: 4421986
The peroxisome proliferator-activated receptor-γ (PPAR-γ) is a member of the nuclear receptor superfamily of ligand-dependent…
Expand
Highly Cited
1995
Highly Cited
1995
Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
G. Hotamisligil
,
P. Arner
,
J. Caro
,
R. Atkinson
,
B. Spiegelman
Journal of Clinical Investigation
1995
Corpus ID: 14488702
Obesity is frequently associated with insulin resistance and abnormal glucose homeostasis. Recent studies in animal models have…
Expand
Highly Cited
1988
Highly Cited
1988
Role of Insulin Resistance in Human Disease
G. Reaven
Diabetes
1988
Corpus ID: 73001621
Resistance to insulin-stimulated glucose uptake is present in the majority of patients with impaired glucose tolerance (IGT) or…
Expand
Highly Cited
1979
Highly Cited
1979
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
R. DeFronzo
,
J. Tobin
,
R. Andres
American Journal of Physiology
1979
Corpus ID: 7192984
Methods for the quantification of beta-cell sensitivity to glucose (hyperglycemic clamp technique) and of tissue sensitivity to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE